Metabolomic-driven prediction of the mutational status of healthy individuals with a family history of hereditary breast and ovarian cancer syndrome: the HRRmet study.

In our study, LPC 16:1 levels were increased in carriers of PVs in PALB2 and CHEK2 (FC = 1.276 and FC = 1.363, respectively), although these increases did not reach statistical significance.

also in 111,027 other papers